Blogs

Generics vs. Namebrand Drugs: Case Studies in Process and Ingredient Variability?

GSK and Spitzer: Schadenfreude?

Interesting Debate on Whether Pharma Should Pull Out of China

Throw Away Those Bibs! Help is at Hand for Infants with GERD

New Talk Show Focuses on Pharma PAT and Quality by Design

Baxter’s Recalled Heparin Might Be Linked to Uninspected Chinese Plant

Should FDA Supervise and Carry Out Clinical Trials?

Seen and Heard at IFPAC

Quality, Schmality: Do You Really Know What All the ICH and QBD Acronyms Mean?